A detailed history of Macquarie Group LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Macquarie Group LTD holds 1,550,692 shares of ABT stock, worth $180 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,550,692
Previous 1,468,351 5.61%
Holding current value
$180 Million
Previous $153 Million 15.87%
% of portfolio
0.2%
Previous 0.18%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $8.24 Million - $9.73 Million
82,341 Added 5.61%
1,550,692 $177 Million
Q2 2024

Aug 09, 2024

BUY
$100.73 - $112.44 $8.45 Million - $9.43 Million
83,900 Added 6.06%
1,468,351 $153 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $24.8 Million - $27.4 Million
226,437 Added 19.55%
1,384,451 $157 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $15.1 Million - $18.5 Million
-167,192 Reduced 12.62%
1,158,014 $127 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $9.11 Million - $10.9 Million
95,346 Added 7.75%
1,325,206 $128 Million
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $45.9 Million - $51.1 Million
455,470 Added 58.82%
1,229,860 $134 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $19.7 Million - $23.2 Million
203,787 Added 35.71%
774,390 $78.4 Million
Q4 2022

Feb 21, 2023

BUY
$95.06 - $111.52 $809,626 - $949,815
8,517 Added 1.52%
570,603 $62.7 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $4.05 Million - $4.69 Million
-41,905 Reduced 6.94%
562,086 $54.4 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $2.55 Million - $3.09 Million
-25,029 Reduced 3.98%
603,991 $65.6 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $2.64 Million - $3.21 Million
-23,110 Reduced 3.54%
629,020 $74.5 Million
Q4 2021

Feb 11, 2022

BUY
$115.53 - $141.46 $23.4 Million - $28.6 Million
202,236 Added 44.95%
652,130 $91.8 Million
Q3 2021

Nov 12, 2021

SELL
$116.66 - $129.06 $154,924 - $171,391
-1,328 Reduced 0.29%
449,894 $53.1 Million
Q2 2021

Aug 13, 2021

BUY
$105.79 - $124.53 $21.2 Million - $25 Million
200,521 Added 79.98%
451,222 $52.3 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $1.45 Million - $1.71 Million
-13,321 Reduced 5.05%
250,701 $30 Million
Q4 2020

Feb 16, 2021

SELL
$105.0 - $114.42 $61.7 Million - $67.2 Million
-587,278 Reduced 68.99%
264,022 $28.9 Million
Q3 2020

Nov 13, 2020

SELL
$91.64 - $111.29 $596 Million - $723 Million
-6,499,373 Reduced 88.42%
851,300 $92.6 Million
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $92.4 Million - $118 Million
-1,206,620 Reduced 14.1%
7,350,673 $672 Million
Q1 2020

May 15, 2020

SELL
$62.82 - $91.86 $136 Million - $199 Million
-2,169,633 Reduced 20.23%
8,557,293 $675 Million
Q4 2019

Feb 14, 2020

BUY
$78.51 - $87.4 $92.7 Million - $103 Million
1,181,225 Added 12.37%
10,726,926 $932 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $4.58 Million - $4.97 Million
-56,022 Reduced 0.58%
9,545,701 $799 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $39.8 Million - $46.4 Million
-546,230 Reduced 5.38%
9,601,723 $808 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $33.8 Million - $40.8 Million
-510,190 Reduced 4.79%
10,147,953 $811 Million
Q4 2018

Feb 15, 2019

SELL
$65.56 - $74.27 $37.1 Million - $42.1 Million
-566,346 Reduced 5.05%
10,658,143 $771 Million
Q3 2018

Nov 15, 2018

SELL
$60.81 - $73.36 $42.2 Million - $51 Million
-694,707 Reduced 5.83%
11,224,489 $823 Million
Q2 2018

Aug 14, 2018

SELL
$57.57 - $63.54 $13.3 Million - $14.6 Million
-230,211 Reduced 1.89%
11,919,196 $727 Million
Q1 2018

May 11, 2018

SELL
$56.27 - $63.62 $47.5 Million - $53.7 Million
-844,281 Reduced 6.5%
12,149,407 $728 Million
Q4 2017

Feb 15, 2018

SELL
$53.68 - $57.47 $44.6 Million - $47.7 Million
-830,718 Reduced 6.01%
12,993,688 $742 Million
Q3 2017

Nov 08, 2017

BUY
$48.06 - $53.64 $664 Million - $742 Million
13,824,406
13,824,406 $738 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.